News archive

Researchers from the Helmholtz Centre for Infection Research in Braunschweig (HZI) together with the InSCREENeX GmbH have developed a universal method with which they can proliferate cells of any donor tissue while maintaining their function. The study has been published in Nature Communications.

The research funding for the replacement and supplementary methods to animal experiments of the State of Baden-Württemberg is entering a new phase. An application is possible until May 15, 2015.

EUSAAT Congress 2018: Call for Abstracts

Friday, 09 March 2018 13:02
From 23 to 26 September, the this year`s 21th Congress on Alternatives to Animal Experiments will take place in Linz (Austria). Participants are encouraged to transmit their abstracts.
From 27 to 29 August, the 12th International Congress and Workshops on Biological Barriers will take place at the Helmholtz Centre for Pharmaceutical Research Saarland (HIPS) at Saarland University in Saarbrücken. In the focus of Biological Barriers are human cell
and tissue models for facilitating clinical translation of new drugs and delivery systems, especially in the context of infectious diseases.
Using cell cultures, spanish researchers have observed that polyphenols in red wine can prevent bacteria from attaching to tooth substance.
The European Union pleads for a worldwide marketing ban on cosmetics tested on animals. Today, in 80 percent of the countries worldwide it is still possible to carry out animal Experiments for cosmetic products or they are demanded.

Scientists at the University Hospital of Ulm are developing a pancreas chip made of stem cells that enables the pharmaceutical industry to test diabetes drugs in high throughput. 

Researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM, report a new organ-on-a-chip technology for the study of blood vessel formation and drugs targeting this event. The technology recreates a human blood vessel and shows how new capillaries grow from a single vessel (parent vessel) in response to proper biochemical signaling cues.

A team of researchers from the William Harvey Research Institute at Queen Mary University of London has succeeded in gaining cells from urine, transforming them into induced pluripotent stem cells and converting them into a Kind of artificial adrenal gland with steroid-producing cells. The model could be used in investigations of possible treatments for adrenal diseases such as adrenal insufficiency.
The Commission for the European Pharmacopoeia and the U. S. Department of Agriculture have agreed that the for years controversial discussed Abnormal Toxicity Test (ATT) for safety assessment of vaccine batches will be deleted from the regulations. From 2019 the test does not being used any longer in Europe.